{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:00:34Z","timestamp":1780473634719,"version":"3.54.1"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyse the current predictive value of isolated high\u2010grade prostatic intraepithelial neoplasia (HGPIN) for clinically significant prostate cancer (csPCa) detection in repeat biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>A cohort of 293 men with isolated HGPIN detected in previous biopsies performed without multiparametric magnetic resonance imaging (mpMRI), and who underwent repeat biopsy within 1 to 3 years, was analysed. Pre\u2010repeat biopsy mpMRI and guided biopsies to suspicious lesions (Prostate Imaging \u2013 Reporting and Data System [PI\u2010RADS] \u22653) and\/or and systematic biopsies were performed. Persistent prostate cancer (PCa) suspicion, defined as sustained serum prostate\u2010specific antigen level &gt;4 ng\/mL and\/or abnormal digital rectal examination, was present in 248 men (84.6%), and was absent in 45 men (15.4%). A control group of 190 men who had no previous HGPIN, atypical small acinar proliferation or HGPIN with atypia who were scheduled to undergo repeat biopsy due to persistent PCa suspicion were also analysed. csPCa was defined as tumours of Grade Group \u22652.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the subset of 45 men with isolated HGPIN, in whom PCa suspicion disappeared, only one csPCa (2.2%) and one insignificant PCa (iPCa) were detected. csPCa was detected in 34.7% of men with persistent PCa suspicion and previous HGPIN, and in 28.4% of those without previous HGPIN (\n                      <jats:italic>P<\/jats:italic>\n                      =0.180). iPCa was detected in 12.1% and 6.3%, respectively (\n                      <jats:italic>P<\/jats:italic>\n                      =0.039). Logistic regression analysis showed that the risk of csPCa detection was not predicted by previous HGPIN: odds ratio (OR) 1.369 (95% confidence interval [CI] 0.894\u20132.095;\n                      <jats:italic>P<\/jats:italic>\n                      =0.149); however, previous HGPIN increased the risk of iPCa detection: OR 2.043 (95% CI 1.016\u20134.109;\n                      <jats:italic>P<\/jats:italic>\n                      =0.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The risk of csPCa in men with isolated HGPIN, in whom PCa suspicion disappears, is extremely low. Moreover, in those men in whom PCa suspicion persists, the risk of csPCa is not influenced by the previous finding of HGPIN. However, previous HGPIN increases the risk of iPCa detection. Therefore, repeat prostate biopsy should not be recommended solely because of a previous HGPIN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.15568","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:08:37Z","timestamp":1628608117000},"page":"627-633","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The current recommendation for the management of isolated high\u2010grade prostatic intraepithelial neoplasia"],"prefix":"10.1111","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-323X","authenticated-orcid":false,"given":"Juan","family":"Morote","sequence":"first","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"},{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Schwartzmann","sequence":"additional","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3128-3811","authenticated-orcid":false,"given":"Anna","family":"Celma","sequence":"additional","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"},{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Roche","sequence":"additional","affiliation":[{"name":"Department of Radiology Vall d\u00b4Hebron Hospital  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s M.","family":"de Torres","sequence":"additional","affiliation":[{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona  Barcelona Spain"},{"name":"Department of Pathology Vall d\u00b4Hebron Hospital  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mast","sequence":"additional","affiliation":[{"name":"Department of Radiology Vall d\u00b4Hebron Hospital  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Semidey","sequence":"additional","affiliation":[{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"},{"name":"Department of Pathology Vall d\u00b4Hebron Hospital  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Regis","sequence":"additional","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"},{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Santamaria","sequence":"additional","affiliation":[{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Planas","sequence":"additional","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"},{"name":"Prostate Cancer Research Group Vall d\u00b4Hebron Research Institute  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Trilla","sequence":"additional","affiliation":[{"name":"Department of Urology Vall d\u00b4Hebron Hospital  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(86)80156-3"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200108000-00014"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00337-X"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.04.016"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.04.021"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.134"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447181"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.08.040"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.05.011"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.04996.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.10.163"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2377-y"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.052"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2017.03.77"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.eururo.2020.02.010","article-title":"Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging\u2010targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta\u2010analysis. Eur Urol 2020;77:78\u201394: Are Targeted Prostate Biopsies Enough in Men with a Previous Negative Biopsy","volume":"77","author":"Morote J","year":"2020","journal-title":"Eur Urol"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11611.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.046"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.03.147"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj131"},{"key":"e_1_2_5_25_1","first-page":"187","article-title":"Atypical small acinar proliferation and two or more cores of high\u2010grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during\u2009a transperineal template\u2010guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume","volume":"9","author":"Nakai Y","year":"2017","journal-title":"Res Rep Urol"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00338-1"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07122.x"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-9-3"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11557.x"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.7634"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2015.56.12.796"},{"key":"e_1_2_5_32_1","first-page":"3","article-title":"Natural history of widespread high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: should we rebiopsy them all","volume":"83","author":"Oderda M","year":"2021","journal-title":"Scand J Urol"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447181"},{"key":"e_1_2_5_34_1","first-page":"187","article-title":"Atypical small acinar proliferation and two or more cores of high\u2010grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template\u2010guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume","volume":"9","author":"Nakai Y","year":"2017","journal-title":"Res Rep Urol"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.08.040"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.15568","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.15568","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.15568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:11:36Z","timestamp":1761754296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.15568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1111\/bju.15568"],"URL":"https:\/\/doi.org\/10.1111\/bju.15568","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"2021-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}